ATE10836T1 - Peptide und ihre anwendung in der therapeutik. - Google Patents

Peptide und ihre anwendung in der therapeutik.

Info

Publication number
ATE10836T1
ATE10836T1 AT81401263T AT81401263T ATE10836T1 AT E10836 T1 ATE10836 T1 AT E10836T1 AT 81401263 T AT81401263 T AT 81401263T AT 81401263 T AT81401263 T AT 81401263T AT E10836 T1 ATE10836 T1 AT E10836T1
Authority
AT
Austria
Prior art keywords
radical
residue
group
carbon atoms
chain
Prior art date
Application number
AT81401263T
Other languages
German (de)
English (en)
Inventor
Bernard Roques
Jeanne Marie Lecomte
Original Assignee
Etablissement Public Dit: Centre National De La Recherche Scientifique (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etablissement Public Dit: Centre National De La Recherche Scientifique (Cnrs) filed Critical Etablissement Public Dit: Centre National De La Recherche Scientifique (Cnrs)
Application granted granted Critical
Publication of ATE10836T1 publication Critical patent/ATE10836T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
    • C07K14/672—Lipotropins, e.g. beta, gamma lipotropin with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT81401263T 1980-08-08 1981-08-05 Peptide und ihre anwendung in der therapeutik. ATE10836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8017523A FR2488253A1 (fr) 1980-08-08 1980-08-08 Nouveaux peptides et leur application en therapeutique
EP81401263A EP0046113B1 (fr) 1980-08-08 1981-08-05 Nouveaux peptides et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
ATE10836T1 true ATE10836T1 (de) 1985-01-15

Family

ID=9245026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81401263T ATE10836T1 (de) 1980-08-08 1981-08-05 Peptide und ihre anwendung in der therapeutik.

Country Status (7)

Country Link
US (1) US4407794A (OSRAM)
EP (1) EP0046113B1 (OSRAM)
JP (1) JPS5759845A (OSRAM)
AT (1) ATE10836T1 (OSRAM)
CA (1) CA1292344C (OSRAM)
DE (1) DE3167826D1 (OSRAM)
FR (1) FR2488253A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516891A (en) * 1992-06-16 1996-05-14 Kinerton, Ltd. Liquid phase synthesis of peptides and peptide derivatives
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
JP2006518759A (ja) * 2003-02-25 2006-08-17 ザ アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティ オブ アリゾナ グリコシル化エンケファリン薬
ATE399763T1 (de) * 2003-05-30 2008-07-15 Prozymex As Proteasehemmer
US20050019422A1 (en) * 2003-07-23 2005-01-27 Allergan, Inc. Method and composition for treating acne
AR049938A1 (es) * 2004-06-25 2006-09-13 Takeda Pharmaceutical Derivados de metastina y utilizacion de los mismos
EP2197470A2 (en) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33177A (da) * 1976-01-26 1977-07-27 Wellcome Found Fremgangsmade til fremstilling af peptider
NZ183712A (en) * 1976-04-08 1979-10-25 Ici Ltd Polypeptide analogues of enkephalins, and pharmaceutical compositions
US4261888A (en) * 1976-04-12 1981-04-14 Sandoz Ltd. Organic compounds
US4259234A (en) * 1976-09-27 1981-03-31 Eli Lilly And Company Analgesic compounds
US4322342A (en) * 1977-06-20 1982-03-30 Eli Lilly And Company Analgesic compounds
US4196122A (en) * 1977-07-01 1980-04-01 American Home Products Corporation Analgesic polypeptide
GB1604644A (en) * 1977-07-22 1981-12-09 Wellcome Found Biologically active pentapeptide amides
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4331593A (en) * 1977-10-03 1982-05-25 Smithwick Jr Edward L Analgesic compounds
US4213968A (en) * 1978-06-05 1980-07-22 Coy David Howard Enkephalin derivatives
US4278596A (en) * 1978-08-08 1981-07-14 American Home Products Corporation Analgesic pentapeptides
US4247543A (en) * 1979-04-09 1981-01-27 Sandoz Ltd. Organic compounds
US4216127A (en) * 1979-07-05 1980-08-05 American Home Products Corporation Enkephalin analogues
US4283329A (en) * 1979-12-17 1981-08-11 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides
US4309343A (en) * 1980-11-25 1982-01-05 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
US4407794A (en) 1983-10-04
EP0046113B1 (fr) 1984-12-19
DE3167826D1 (en) 1985-01-31
EP0046113A1 (fr) 1982-02-17
JPS5759845A (en) 1982-04-10
CA1292344C (en) 1991-11-19
FR2488253B1 (OSRAM) 1984-01-27
FR2488253A1 (fr) 1982-02-12

Similar Documents

Publication Publication Date Title
ATE10836T1 (de) Peptide und ihre anwendung in der therapeutik.
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
LV5794A4 (lv) Nonapeptidi ar bombezina antagonistu ipasibam
ES2095942T3 (es) Derivados de bencenoacetamida inhibidores del vih.
HUP9800147A1 (hu) Izoxazol- és krotonsav-amid-származékok és ezeket tartalmazó gyógyszer- és diagnosztikai készítmények
ATE19251T1 (de) Hemmer der kollagenase der saeugetiere.
BG101484A (bg) Използване на естери на 3-арилакрилова киселина като средства за защита от светлина и като стабилизатори на нежив органичен материал
ATE8252T1 (de) Pharmakologisch wirksame pentapeptid derivate.
ES393681A1 (es) Procedimiento para la preparacion de esteres de sulfoxido de cefalosporina.
ES8707550A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos.
IL61560A0 (en) 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
ES437586A1 (es) Procedimiento para la produccion de un peptido.
FI870811A7 (fi) Pentapeptider med en cellvaextreglerande effekt och ett foerfarande foer framstaellning av desamma.
SE8703623D0 (sv) Komposition innefattande ett stannoreduceringsmedel och n-substituerade iminodiettiksyror
SE7909653L (sv) Tyrosylerade proinsulin c-peptidderivat
TR200003654T2 (tr) 3-(2-okso-(1,3')bipirolidinil-3-ilidenemetil)-sefem türevleri.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee